Almirall Announces “LumiNE”, a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema January 16, 2026 Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a potentially promising therapeutic option. LumiNE is part of Almirall’s ongoing lifecycle management activities to enable more patients to benefit from advanced treatments - such as Lebrikizumab - targeting patients with dermatological conditions and high unmet medical needs. The phase III study will be initiated within the first half of 2026 and will evaluate the efficacy, safety, and tolerability of lebrikizumab in at least 270 patients with nummular eczema in Europe for up to 48 weeks of treatment.
Northern Trust Asset Management Forecasts AI-Driven Strength in Private Markets; United States, Japan and Australia to Lead Equity Returns over Next Decade January 16, 2026 AI innovation, the global shift to self-reliance and rising government debt likely to be key drivers of financial markets
Rapyd’s 2026 State of Stablecoins: Businesses Move En Masse as Stablecoins Go Mainstream January 16, 2026 Rapyd’s 2026 State of Stablecoins Report shows 64% of businesses surveyed already use stablecoins or plan to within three years, with speed, easier cross-border transactions, and cost savings driving adoption
Everest Appoints Christopher Kujawa as Executive Vice President and Chief Human Resources Officer January 16, 2026 Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing world-class reinsurance and specialty insurance solutions, announced today that Christopher Kujawa has been appointed Executive Vice President and Chief Human Resources Officer, effective January 20, 2026. Mr. Kujawa will report to Jim Williamson, President and CEO and will serve on Everest’s Executive Leadership Team. He [...]
Primient to Acquire Full Ownership of Primient Covation, LLC January 16, 2026 Primient, a global leader in biomanufacturing, announced today it has agreed to purchase the remaining ownership interest in Primient Covation, LLC (“Primient Covation”), establishing Primient as the sole owner of the company and marking an exciting new chapter in Primient’s growth in the bioeconomy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114344080/en/ [...]
Accertify Appoints CEO and Expands Executive Team to Fuel Next Phase of Growth January 16, 2026 Greg Dukat appointed CEO as Accertify builds leadership depth to accelerate go-to-market execution
Almirall Presents R&D Pipeline Advances Supported by Sustained Growth and Leadership in Medical Dermatology at J.P. Morgan Healthcare Conference January 16, 2026 Pipeline advances in 2026 span a range of dermatology disease areas, including atopic dermatitis, hidradenitis suppurativa, and alopecia areata, with 3 ongoing PoC/Phase II clinical studies* and 3 additional studies to be initiated in 2026. Almirall’s sustained trajectory of growth and profitability enables the company to reach more patients and supports a growth outlook of double-digit net sales through 2030, combined biologics peak sales of approximately €800 MM (Ebglyss® and Ilumetri®), and a 25% EBITDA margin by 2028. Almirall's leadership in medical dermatology, biologics growth, and continued strong performance of its broad product portfolio fuel advancement of a diversified and innovative R&D pipeline addressing skin diseases with high unmet need.
ReNew Achieves ‘A’ Rating in CDP Climate Change Assessment, Advancing to Global Leadership Band January 16, 2026 Elevated its score by two levels, advancing from a ‘B’ in FY 2023–24 to an ‘A’ in FY 2024–25 — placing ReNew among global leaders in climate disclosure Retains a strong ‘A-’ rating in CDP Water Security, ranking among the world’s top energy companies for environmental transparency
KBRA Releases Research – 2026 European Project Finance and Infrastructure Sector Outlook: Stable Credit Quality Amid AI Energy Crosswinds January 16, 2026 KBRA releases its 2026 European project finance and infrastructure (PF&I) Sector Outlook, examining themes that will likely take centre stage in 2026 as well as developments and ratings trends from 2025. The European PF&I sector displayed broadly stable credit quality in 2025, and KBRA expects continued stability in 2026. The credit backdrop is supported by [...]
The Capitalist: Lord Sugar forsakes Zoom etiquette at Apprentice Q&A January 15, 2026 Lord Sugar's Zoom faux pas at Apprentice Q&A, Benedict Cumberbatch's Nimby campaign and a dry January for the BBPA in this week's The Capitalist.